Literature DB >> 10364218

Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho.

M Sekimata1, Y Kabuyama, Y Emori, Y Homma.   

Abstract

We recently cloned a novel signaling molecule, p122, that shows a GTPase-activating activity specific for Rho and the ability to enhance the phosphatidylinositol 4,5-bisphosphate-hydrolyzing activity of phospholipase C delta1 in vitro. Here we analyzed the in vivo function of p122. Microinjection of the GTPase-activating domain of p122 suppressed the formation of stress fibers and focal adhesions induced by lysophosphatidic acid, suggesting a GTPase-activating activity for Rho as in in vitro. Transfection of p122 also induced the disassembly of stress fibers and the morphological rounding of various adherent cells. Analyses using deletion and point mutants demonstrated that the GTPase-activating domain of p122 is responsible for the morphological changes and detachment and that arginine residues at positions 668 and 710 and a lysine residue at position 706 in the GTPase-activating domain are essential. Using Fluo-3-based Ca2+ microscopy, we found that p122 evoked a rapid elevation of intracellular Ca2+ levels, suggesting that p122 stimulates the phosphatidylinositol 4, 5-bisphosphate-hydrolyzing activity of phospholipase C delta1. These results demonstrate that p122 synergistically functions as a GTPase-activating protein specific for Rho and an activator of phospholipase C delta1 in vivo and induces morphological changes and detachment through cytoskeletal reorganization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364218     DOI: 10.1074/jbc.274.25.17757

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation.

Authors:  Huina Liu; Huirong Shi; Yibin Hao; Guoqiang Zhao; Xiaofeng Yang; Yali Wang; Mei Li; Min Liu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

2.  Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.

Authors:  Thomas Ho-Yin Leung; Yick-Pang Ching; Judy Wai Ping Yam; Chun-Ming Wong; Tai-On Yau; Dong-Yan Jin; Irene Oi-Lin Ng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

3.  DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt's lymphoma cells.

Authors:  Minhua Feng; Bo Huang; Zunguo Du; Xiaoping Xu; Zi Chen
Journal:  Mol Biol Rep       Date:  2010-10-01       Impact factor: 2.316

4.  A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.

Authors:  J S W Low; Q Tao; K M Ng; H K Goh; X-S Shu; W L Woo; R F Ambinder; G Srivastava; M Shamay; A T C Chan; N C Popescu; W-S Hsieh
Journal:  Oncogene       Date:  2011-01-10       Impact factor: 9.867

5.  In vitro analysis of the anticancer activity of Lysinibacillus sphaericus binary toxin in human cancer cell lines.

Authors:  Wasutorn Chankamngoen; Tavan Janvilisri; Boonhiang Promdonkoy; Panadda Boonserm
Journal:  3 Biotech       Date:  2020-07-31       Impact factor: 2.406

6.  Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.

Authors:  Yi-Chun Liao; Yi-Ping Shih; Su Hao Lo
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.

Authors:  Mohammad G Sabbir; Nichola Wigle; Shauna Loewen; Yuan Gu; Cordula Buse; Geoffrey G Hicks; Michael R A Mowat
Journal:  BMC Biol       Date:  2010-03-03       Impact factor: 7.431

8.  The RhoGAP activity of CYK-4/MgcRacGAP functions non-canonically by promoting RhoA activation during cytokinesis.

Authors:  Donglei Zhang; Michael Glotzer
Journal:  Elife       Date:  2015-08-07       Impact factor: 8.140

9.  DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain.

Authors:  Patrik Erlmann; Simone Schmid; Florian A Horenkamp; Matthias Geyer; Thomas G Pomorski; Monilola A Olayioye
Journal:  Mol Biol Cell       Date:  2009-08-26       Impact factor: 4.138

Review 10.  Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Authors:  Nicholas C Popescu; Steve Goodison
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.